Search research articles
Contact Us
Filters
Showing results (21-30 of 26) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1996
Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells
M A Varney, C Jachec, C Deal, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2009
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia
B G Oertel, L Felden, P V Tran, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5
M A Varney, N D Cosford, C Jachec, et al.
Journal of Neurochemistry
|
November 3, 1998
The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression
L P Daggett, E C Johnson, M A Varney, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo
F Gasparini, V Bruno, G Battaglia, et al.
Neuropharmacology
|
October 26, 1999
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
F Gasparini, K Lingenhöhl, N Stoehr, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 26) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 26 results.
The Journal of Pharmacology and Experimental Therapeutics
|
October 1, 1996
Stable expression and characterization of recombinant human heteromeric N-methyl-D-aspartate receptor subtypes NMDAR1A/2A and NMDAR1A/2B in mammalian cells
M A Varney, C Jachec, C Deal, et al.
Clinical Pharmacology and Therapeutics
|
November 13, 2009
Selective antagonism of opioid-induced ventilatory depression by an ampakine molecule in humans without loss of opioid analgesia
B G Oertel, L Felden, P V Tran, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
June 25, 1999
SIB-1757 and SIB-1893: selective, noncompetitive antagonists of metabotropic glutamate receptor type 5
M A Varney, N D Cosford, C Jachec, et al.
Journal of Neurochemistry
|
November 3, 1998
The human N-methyl-D-aspartate receptor 2C subunit: genomic analysis, distribution in human brain, and functional expression
L P Daggett, E C Johnson, M A Varney, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 21, 1999
(R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo
F Gasparini, V Bruno, G Battaglia, et al.
Neuropharmacology
|
October 26, 1999
2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist
F Gasparini, K Lingenhöhl, N Stoehr, et al.
Page
of 3